Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases

Documenti analoghi

• Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease
  di: Angeliki Zarkali, et al.
  Pubblicazione: (2025)
• Neuroimaging and plasma biomarker differences and commonalities in Lewy body dementia subtypes
  di: Naomi Hannaway, et al.
  Pubblicazione: (2025)
• Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology
  di: Christian Rummey, et al.
  Pubblicazione: (2025)
• Monoaminergic Networks of Cognitive and Behavioral Symptoms in Early Parkinson's Disease
  di: Kalle J. Niemi, et al.
  Pubblicazione: (2026)
• GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders
  di: Eliza M. Brody, et al.
  Pubblicazione: (2024)